Ford, J, Cummins, E, Sharma, P, Elders, A, Stewart, F, Johnston, R, Royle, P, Jones, R, Mulatero, C, Todd, R and Mowatt, G (2013) Systematic review of the clinical effectiveness and cost-effectiveness, and economic evaluation, of denosumab for the treatment of bone metastases from solid tumours. Health Technology Assessment, 17 (29). pp. 1-386. ISSN 1366-5278

Full text not available from this repository. (Request a copy)

Abstract

Denosumab offers an alternative, or additional, treatment for the prevention of skeletal-related events (SREs) in patients with bone metastases from solid tumours.

Item Type:	Article
Uncontrolled Keywords:	antibodies, monoclonal, humanized,bone density conservation agents,bone neoplasms,breast neoplasms,cost-benefit analysis,female,humans,lung neoplasms,male,models, economic,prostatic neoplasms,quality-adjusted life years,randomized controlled trials as topic
Faculty \ School:	Faculty of Medicine and Health Sciences > Norwich Medical School Faculty of Science > School of Chemistry
Depositing User:	Pure Connector
Date Deposited:	12 Nov 2014 16:50
Last Modified:	06 May 2022 01:28
URI:	https://ueaeprints.uea.ac.uk/id/eprint/50668
DOI:	10.3310/hta17290

Actions (login required)

View Item